HS
HighVista Strategies’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91M | Buy |
67,499
+20,999
| +45% | +$907K | 1.07% | 19 |
|
|
2025
Q1 | $1.61M | Hold |
46,500
| – | – | 0.62% | 60 |
|
|
2024
Q4 | $1.28M | Sell |
46,500
-22,554
| -33% | -$619K | 0.47% | 94 |
|
|
2024
Q3 | $1.76M | Buy |
69,054
+24,482
| +55% | +$623K | 0.61% | 62 |
|
|
2024
Q2 | $1.13M | Sell |
44,572
-11,990
| -21% | -$304K | 0.41% | 98 |
|
|
2024
Q1 | $1.75M | Buy |
56,562
+11,990
| +27% | +$371K | 0.62% | 55 |
|
|
2023
Q4 | $1.8M | Hold |
44,572
| – | – | 0.65% | 51 |
|
|
2023
Q3 | $1.18M | Buy |
+44,572
| New | +$1.18M | 0.54% | 51 |
|
|
2022
Q3 | – | Sell |
-105,942
| Closed | -$962K | – | 115 |
|
|
2022
Q2 | $962K | Buy |
105,942
+20,642
| +24% | +$187K | 0.58% | 39 |
|
|
2022
Q1 | $866K | Buy |
85,300
+51,450
| +152% | +$522K | 0.55% | 51 |
|
|
2021
Q4 | $565K | Buy |
33,850
+9,198
| +37% | +$154K | 0.45% | 63 |
|
|
2021
Q3 | $1.16M | Buy |
24,652
+11,596
| +89% | +$543K | 0.76% | 41 |
|
|
2021
Q2 | $796K | Buy |
+13,056
| New | +$796K | 0.56% | 50 |
|